Sat, June 20, 2026
AUS Edition NZ Edition UK Edition
CA Edition USA Edition IND Edition
Kalkine Media ASX Share Market News & Research
Kalkine Media ASX Share Market News & Research
  1. Home
  2. Companies
  3. TCMD
Healthcare
Facebook Twitter Linkedin

Tactile Systems Technology Inc (NASDAQ:TCMD)

26.62 USD

+0.790 3.059%
Last Updated at: 2026-06-18T20:01:00Z

Tactile Systems Technology Inc

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

3701 Wayzata Boulevard, Minneapolis, MN, United States, 55416

612 355 5100

https://tactilemedical.com

Employees: 992

Key Executives

Sr. No. Name Title Year Born
1. Mr. Daniel L. Reuvers Pres, CEO & Director 1963
2. Mr. Brent A. Moen Chief Financial Officer 1967
3. Ms. Kristie T. Burns Sr. VP of Marketing & Clinical Affairs 1972
4. Mr. Eric C. Pauls Sr. VP of Sales 1975
5. Mr. Jerry A. Sauber VP of Operations NA
6. Mr. Peter C. Schaubach Chief Information Officer NA
7. Ms. Sunday J. Hoy VP & Compliance Officer NA
8. Janelle Strop Chief Human Resource Officer NA
9. Mr. Thomas F. O'Donnell Jr., M.D. Chief Medical Officer & Member of Vascular Strategic Advisory Board NA
10. Mr. Daniel L. Reuvers President, CEO & Director 1963

Peers

Sector: Healthcare

Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE(x) Forward PE(x) Price Sales TTM(x) Price to Book Value(x) Enterprise Value to Revenue(x) Enterprise Value to EBITDA(x)
ABT

Abbott Laboratories

 -0.090 0.102% 88.64 25.970 17.241 3.570 3.200 3.805 16.753
SYK

Stryker Corporation

 +6.660 2.212% 301.19 44.070 24.938 5.509 6.118 6.050 25.731
MDT

Medtronic PLC

 +1.200 1.536% 78.59 26.600 15.873 3.354 2.083 3.897 14.117
BSX

Boston Scientific Corp

 +0.340 0.756% 45.06 31.490 17.241 4.407 3.650 4.878 19.194

Income Statement

(Currency in USD)
Breakdown 31-12-2022 31-12-2021 31-12-2020 31-12-2019 31-12-2018
Income Before Tax -15.473M -2.293M -2.261M 11.129M 3.476M
Minority Interest - - - - -
Net Income -17.866M -11.811M -0.62M 10.971M 6.623M
Selling General Administrative 60.796M 56.802M 51.54M 39.644M 33.608M
Gross Profit 175.976M 148.213M 132.81M 134.236M 102.258M
Reconciled Depreciation 6.268M 3.681M 2.794M 3.538M 3.635M
Ebit -4.594M -1.762M -3.628M 10.498M 2.99M
Ebitda 1.674M 1.919M -0.834M 14.036M 6.625M
Depreciation And Amortization 6.268M 3.681M 2.794M 3.538M 3.635M
Operating Income -4.594M -1.762M -3.628M 10.498M 2.99M
Other Operating Expenses 259.543M 209.819M 190.758M 178.994M 140.761M
Interest Expense 10.879M 0.531M 1.367M 0.631M 0M
Tax Provision 2.393M 9.518M -1.641M 0.158M -3.147M
Interest Income - - - - -
Net Interest Income - - - - -
Income Tax Expense 2.393M 9.518M -1.641M 0.158M -3.147M
Total Revenue 246.785M 208.057M 187.13M 189.492M 143.751M
Total Operating Expenses 188.734M 149.975M 136.438M 123.738M 99.268M
Cost Of Revenue 70.809M 59.844M 54.32M 55.256M 41.493M
Total Other Income Expense Net -10.879M -0.531M 1.367M 0.631M 0.486M
Net Income From Continuing Ops -17.866M -11.811M -0.62M 10.971M 6.623M
Net Income Applicable To Common Shares -17.866M -11.811M -0.62M 10.971M 6.623M

Balance Sheet

(Currency in USD)
Breakdown 31-12-2023 31-12-2022 31-12-2021 31-12-2020 31-12-2019
Total Assets 281.438M 254.996M 244.27M 174.087M 151.752M
Intangible Assets 46.724M 50.375M 54.081M 1.68M 5.312M
Other Current Assets 4.366M 3.754M 4.141M 2.638M 2.451M
Total Liab 87.796M 133.596M 116.043M 49.337M 39.157M
Total Stockholder Equity 193.642M 121.4M 128.227M 124.75M 112.595M
Other Current Liab 4.475M 48.878M 3.305M 1.842M 0.903M
Common Stock 0.024M 0.02M 0.02M 0.019M 0.019M
Capital Stock 0.024M 0.02M 0.02M 0.019M 0.019M
Retained Earnings 18.894M -9.621M 8.245M 20.056M 20.676M
Good Will 31.063M 31.063M 31.063M - -
Other Assets - 26.096M 14.845M 41.837M 14.112M
Cash 61.033M 21.929M 28.229M 47.855M 22.77M
Cash And Equivalents - - - - -
Total Current Liabilities 41.057M 64.33M 34.461M 26.714M 21.428M
Current Deferred Revenue 24.16M - 17.417M 18.669M 15.228M
Net Debt -10.658M 50.3M 55.631M -26.461M -6.182M
Short Term Debt 5.763M 5.468M 8.716M 2.006M 1.454M
Short Long Term Debt 2.956M 2.968M 6.21M - -
Short Long Term Debt Total 50.375M 72.229M 83.86M 21.394M 16.588M
Other Stockholder Equity 174.724M 131.001M 119.962M 104.675M 91.874M
Property Plant Equipment - 6.077M 6.75M 6.957M 23.293M
Total Current Assets 145.294M 119.763M 113.547M 123.613M 108.335M
Long Term Investments - - - - 0.65M
Short Term Investments 14.195M 16.13M 12.482M 10.708M 30.611M
Net Receivables 43.173M 54.826M 49.478M 43.849M 33.444M
Long Term Debt 26.176M 45.895M 51.79M - -
Inventory 22.527M 23.124M 19.217M 18.563M 19.059M
Accounts Payable 6.659M 9.984M 5.023M 4.197M 3.843M
Accumulated Other Comprehensive Income 0M - - - 0.026M
Non Currrent Assets Other 13.356M 26.396M 14.845M 2.074M 1.658M
Non Current Assets Total 136.144M 135.233M 130.723M 50.474M 43.417M
Capital Lease Obligations 21.243M 23.366M 25.86M 21.394M 16.588M
Long Term Debt Total - 45.895M 51.79M - -

Cash Flow

(Currency in USD)
Breakdown 31-12-2022 31-12-2021 31-12-2020 31-12-2019 31-12-2018
Investments -1.909M -82.184M 22.47M 3.653M -5.18M
Total Cashflows From Investing Activities -1.909M -82.184M 20.179M -2.335M -14.726M
Total Cash From Financing Activities -9.6M 59.927M 2.112M 2.496M 1.85M
Net Income -17.866M -11.811M -0.62M 10.971M 6.623M
Change In Cash -6.3M -19.626M 25.085M 2.671M -3.869M
Begin Period Cash Flow 28.229M 47.855M 22.77M 20.099M 23.968M
End Period Cash Flow 21.929M 28.229M 47.855M 22.77M 20.099M
Total Cash From Operating Activities 5.209M 2.631M 2.794M 2.51M 9.007M
Depreciation 6.268M 3.681M 2.794M 3.538M 3.635M
Other Cashflows From Investing Activities -0.129M -80.081M -0.232M -0.542M -5.35M
Dividends Paid - - - - 0M
Change To Inventory -3.907M 0.972M 0.318M -7.87M -0.87M
Sale Purchase Of Stock 1.286M 2.312M 2.898M 3.053M 2.714M
Other Cashflows From Financing Activities -4.886M 57.615M -0.786M -0.557M -3.578M
Capital Expenditures 1.92M 2.355M 2.291M 5.988M 9.546M
Change In Working Capital -4.631M -9.462M -12.759M -22.525M -5.581M
Other Non Cash Items 11.87M -0.18M 3.923M 0.848M 2.538M
Free Cash Flow 3.289M 0.276M 0.503M -3.478M -0.539M

Funds

Sr. No. Name Purchased On Shares
1. Vanguard Total Stock Mkt Idx Inv 2 years ago 753016
2. iShares Russell 2000 ETF 2 years ago 544965
3. CREF Stock R1 2 years ago 432390
4. Kennedy Micro Cap 2 years ago 425532
5. Vanguard Institutional Extnd Mkt Idx Tr 2 years ago 358088
6. Royce Small-Cap Opportunity Invmt 2 years ago 330227
7. Paradigm Micro-Cap 2 years ago 300000
8. Wasatch Micro Cap Value 2 years ago 248526
9. APO Medical Opportunities R 2 years ago 245000
10. Fidelity Small Cap Index 2 years ago 236621
11. BlackRock Advantage Small Cap Core Instl 2 years ago 224110
12. DFA US Targeted Value I 2 years ago 222881
13. iShares Russell 2000 Growth ETF 2 years ago 196604
14. FTGF RY US SmCp Opp A USD Dis(A) 2 years ago 191841
15. Federated Hermes MDT SCC Institutional 2 years ago 180580
16. Federated Hermes MDT Small Cap Core IS 2 years ago 180580
17. Nuveen Small-Cap Value Opps I 2 years ago 172312
18. Federated Hermes MDT SCG Institutional 2 years ago 150503
19. Federated Hermes MDT Small Cap Growth IS 2 years ago 150503
20. State St Russell Sm/Mid Cp® Indx NL Cl C 2 years ago 145289

Institutions

Sr. No. Name Purchased On Shares
1. First Light Asset Management, LLC 2 years ago 2641975
2. BlackRock Inc 2 years ago 2425168
3. Cadian Capital Management LP 2 years ago 1928031
4. Vanguard Group Inc 2 years ago 1383366
5. Perceptive Advisors LLC 2 years ago 903085
6. Dimensional Fund Advisors, Inc. 2 years ago 829197
7. State Street Corporation 2 years ago 729713
8. Next Century Growth Investors LLC 2 years ago 718970
9. Paradigm Capital Management, Inc. 2 years ago 622727
10. Royce & Associates, LP 2 years ago 538376
11. Wasatch Advisors LP 2 years ago 534565
12. Geode Capital Management, LLC 2 years ago 513697
13. Kennedy Capital Management Inc 2 years ago 464764
14. Goldman Sachs Group Inc 2 years ago 461072
15. Federated Hermes Inc 2 years ago 342700
16. Renaissance Technologies Corp 2 years ago 328400
17. Ameriprise Financial Inc 2 years ago 306112
18. Blair William & Co 2 years ago 298545
19. Tocqueville Asset Management L.P. 2 years ago 267339
20. AQR Capital Management LLC 2 years ago 264470
Disclaimer

Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Sponsored Articles

Related Articles

Code Price Chg %Chg
View All
Code Price Chg %Chg
View All
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Open in the App